Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion
- 1 October 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 120 (4) , 801-807
- https://doi.org/10.1016/0002-8703(90)90195-4
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Amphipathic metabolites and membrane dysfunction in ischemic myocardium.Circulation Research, 1984
- Lipid alterations induced by renal ischemia: Pathogenic factor in membrane damageKidney International, 1984
- Relationship between lysophospholipid accumulation and plasma membrane injury during total in vitro ischemia in dog heart*Journal of Molecular and Cellular Cardiology, 1984
- Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect.Circulation Research, 1981
- Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium.Circulation Research, 1981
- Microsomal membrane structure and function subsequent to calcium activation of an endogenous phospholipaseArchives of Biochemistry and Biophysics, 1980
- Cytolytic and membrane-perturbing properties of lysophosphatidylcholineBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1979
- Phospholipase A activity of highly enriched preparations of cardiac sarcolemma from hamster and dogJournal of Molecular and Cellular Cardiology, 1978
- Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.Journal of Clinical Investigation, 1978
- Inhibitory Effect of Lysolecithin on Electron Transfer from NADH to Cytochrome bThe Journal of Biochemistry, 1968